InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.00%
)
US TECH 100
19,186.80
(
-0.15%
)
Dow Jones
39,127.80
(
0.00%
)
Brent Oil
85.07
(
0.70%
)
Bitcoin
61,213.31
(
0.66%
)
Post# of 8739
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jamtomorrow2

Send PM Follow Ignore
Followers 0
Posts 178
Boards Moderated 0
Alias Born 12/04/2013

jamtomorrow2

Re: rod5247 post# 5027

Wednesday, 12/14/2016 5:02:41 PM

Wednesday, December 14, 2016 5:02:41 PM

Post# of 8739
I note that the Gilead drug took over a year to be approved after the trial was stopped due to overwhelming data in its favour. No rush then for the FDA to save patients lives! Something to bear in mind.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HALO News
More HALO News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!